If any controlled substance appears in the listed bulk database, please ignore it, as we do not supply or offer controlled substances.
Rapamycin Impurity 18
100% accuracy
of data
24/7 scientific
support
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Rapamycin Impurity 18

● In Stock

Catalogue No.:VE0017233
CAS No.:N/A
Mol. Formula:C51H77NO12
Mol. Weight:896.17 g/mol

Additional information on Rapamycin Impurity 18

Parent drug

Rapamycin

IUPAC Name

(4R, 7S, 9a’S)-7-((2S, 3E, 5E, 7E, 9S, 11R, 13R, 14R, 15E, 17R, 19E, 21R)-14-hydroxy-22-((1S, 3R, 4R)-4-hydroxy-3-methoxycyclohexyl)-2, 13-dimethoxy-3, 9, 11, 15, 17, 21-hexamethyl-12, 18-dioxodocosa-3, 5, 7, 15, 19-pentaen-1-yl)-4-methyltetrahydro-1’H-spiro[oxepane-2, 3′-pyrido[2, 1-c][1, 4]oxazine]-1′, 3, 4′(6’H)-trione

Synonyms

N/A

Smiles

O=C([C@@](CCCC1)([H])N1C2=O)OC32O[C@H](C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C([C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(/C=C/[C@H](C)C[C@H]4C[C@@H](OC)[C@H](O)CC4)=O)=O)CC[C@@H](C)C3=O

InChI

InChI=1S/C51H77NO12/c1-31(26-36(6)45(55)47(62-10)46(56)37(7)28-35(5)41(53)23-19-32(2)27-38-21-24-42(54)44(29-38)61-9)16-12-11-13-17-33(3)43(60-8)30-39-22-20-34(4)48(57)51(63-39)50(59)52-25-15-14-18-40(52)49(58)64-51/h11-13,16-17,19,23,28,31-32,34-36,38-40,42-44,46-47,54,56H,14-15,18,20-22,24-27,29-30H2,1-10H3/b13-11+,16-12+,23-19+,33-17+,37-28+/t31-,32+,34-,35-,36-,38+,39+,40+,42-,43+,44-,46-,47+,51?/m1/s1

Description

The compound Rapamycin Impurity 18 is a highly characterized reference material that meets stringent regulatory standards, including those set by USP, EMA, JP, and BP. This product is essential for a variety of applications, such as analytical method development, method validation (AMV), and Quality Control (QC), particularly in the context of Rapamycin production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). Additionally, the product comes with a detailed Structure Elucidation Report (SER), ensuring its precision and reliability for comprehensive analytical use.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Products quotation
Name
Url
 
This field is hidden when viewing the form
This field is hidden when viewing the form